Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial.

Masuda N, Toi M, Yamamoto N, Iwata H, Kuroi K, Bando H, Ohtani S, Takano T, Inoue K, Yanagita Y, Kasai H, Morita S, Sakurai T, Ohno S.

Breast Cancer. 2018 Jul;25(4):407-415. doi: 10.1007/s12282-018-0839-7. Epub 2018 Feb 14.

2.

Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01).

Fujii T, Horiguchi J, Yanagita Y, Koibuchi Y, Ikeda F, Uchida N, Kimura M; GUNMA BREAST CLINICAL CONFERENCE STUDY GROUP (GBCCSG).

Anticancer Res. 2018 Feb;38(2):905-909.

PMID:
29374719
3.

The role of biomass allocation between lamina and petioles in a game of light competition in a dense stand of an annual plant.

Yoshinaka K, Nagashima H, Yanagita Y, Hikosaka K.

Ann Bot. 2018 Apr 18;121(5):1055-1064. doi: 10.1093/aob/mcy001.

PMID:
29365041
4.

Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study.

Shien T, Doihara H, Sato N, Anan K, Komaki K, Miyauchi K, Yanagita Y, Fujisawa T, Mitsuyama S, Kanbayashi C, Kusama M, Kimura M, Jinno H, Sano M, Ikeda T.

Cancer Chemother Pharmacol. 2018 Feb;81(2):269-275. doi: 10.1007/s00280-017-3491-6. Epub 2017 Dec 1.

5.

Characterization of poly(L-glutamic acid)-grafted hyaluronan as a novel candidate medicine and biomedical device for intra-articular injection.

Muramatsu K, Tajima Y, Kaneko R, Yanagita Y, Hirai H, Hiura N.

J Biomed Mater Res A. 2017 Nov;105(11):3006-3016. doi: 10.1002/jbm.a.36155. Epub 2017 Aug 9.

PMID:
28675666
6.

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.

Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M.

N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645.

7.

Unified Total Synthesis of Madangamines A, C, and E.

Suto T, Yanagita Y, Nagashima Y, Takikawa S, Kurosu Y, Matsuo N, Sato T, Chida N.

J Am Chem Soc. 2017 Mar 1;139(8):2952-2955. doi: 10.1021/jacs.7b00807. Epub 2017 Feb 16.

PMID:
28190360
8.

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.

Kubota K, Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T.

Support Care Cancer. 2016 Sep;24(9):4025-33. doi: 10.1007/s00520-016-3203-5. Epub 2016 Apr 29.

9.

Factors associated with the annual change in forced expiratory volume in 1 second of officially acknowledged victims of pollution-related illness in improved environments: a longitudinal study.

Yano Y, Senjyu H, Tanaka T, Asai M, Yanagita Y, Nishinakagawa T, Miyamoto N, Kotaki K, Kozu R, Honda S.

J Phys Ther Sci. 2015 May;27(5):1411-6. doi: 10.1589/jpts.27.1411. Epub 2015 May 26.

10.

Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.

Yajima R, Yajima T, Fujii T, Yanagita Y, Fujisawa T, Miyamoto T, Tsutsumi S, Iijima M, Kuwano H.

Breast Cancer. 2016 Jul;23(4):668-74. doi: 10.1007/s12282-015-0622-y. Epub 2015 Jun 14.

PMID:
26071015
11.

Synthesis of diazatricyclic common structure of madangamine alkaloids.

Yanagita Y, Suto T, Matsuo N, Kurosu Y, Sato T, Chida N.

Org Lett. 2015 Apr 17;17(8):1946-9. doi: 10.1021/acs.orglett.5b00661. Epub 2015 Mar 27.

PMID:
25815528
12.

Smoking aggravates the impaired pulmonary function of officially acknowledged female victims of air pollution of 40 years ago.

Nishinakagawa T, Senjyu H, Tanaka T, Asai M, Kotaki K, Yano Y, Miyamoto N, Yanagita Y, Kozu R, Tabusadani M, Honda S.

Tohoku J Exp Med. 2014 Oct;234(2):151-60.

13.

Tobacco use among designated air pollution victims and its association with lung function and respiratory symptoms: a retrospective cross-sectional study.

Kotaki K, Senjyu H, Tanaka T, Yano Y, Miyamoto N, Nishinakagawa T, Yanagita Y, Asai M, Kozu R, Tabusadani M, Sawai T, Honda S.

BMJ Open. 2014 Jul 31;4(7):e005393. doi: 10.1136/bmjopen-2014-005393.

14.

Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer.

Yajima R, Fujii T, Yanagita Y, Fujisawa T, Miyamoto T, Hirakata T, Tsutsumi S, Iijima M, Kuwano H.

Ann Surg Oncol. 2015 Jan;22(1):52-8. doi: 10.1245/s10434-014-3941-x. Epub 2014 Jul 25.

PMID:
25059790
15.

Extracapsular invasion of sentinel lymph nodes is not associated with disease recurrence in breast cancer.

Fujii T, Yajima R, Yamaguchi S, Yanagita Y, Fujisawa T, Hirakata T, Tsutsumi S, Asao T, Iijima M, Kuwano H.

Int Surg. 2014 Jul-Aug;99(4):305-8. doi: 10.9738/INTSURG-D-13-00012.1.

16.

Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study).

Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M.

Breast Cancer Res Treat. 2014 May;145(1):143-53. doi: 10.1007/s10549-014-2907-9. Epub 2014 Mar 30.

17.

Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PET.

Hirakata T, Yanagita Y, Fujisawa T, Fujii T, Kinoshita T, Horikoshi H, Oya N, Akiyoshi T, Iijima M, Miyamoto T, Kuwano H.

Anticancer Res. 2014 Jan;34(1):221-6.

PMID:
24403466
18.

Pulmonary rehabilitation improves exercise capacity and dyspnea in air pollution-related respiratory disease.

Miyamoto N, Senjyu H, Tanaka T, Asai M, Yanagita Y, Yano Y, Nishinakagawa T, Kotaki K, Kitagawa C, Rikitomi N, Kozu R, Honda S.

Tohoku J Exp Med. 2014 Jan;232(1):1-8.

19.

Longitudinal study of respiratory function and symptoms in a non-smoking group of long-term officially-acknowledged victims of pollution-related illness.

Tanaka T, Asai M, Yanagita Y, Nishinakagawa T, Miyamoto N, Kotaki K, Yano Y, Kozu R, Honda S, Senjyu H.

BMC Public Health. 2013 Aug 17;13:766. doi: 10.1186/1471-2458-13-766.

20.

Air pollution irreversibly impairs lung function: a twenty-year follow-up of officially acknowledged victims in Japan.

Yanagita Y, Senjyu H, Asai M, Tanaka T, Yano Y, Miyamoto N, Nishinakagawa T, Kotaki K, Kozu R, Tabusadani M, Honda S.

Tohoku J Exp Med. 2013 Jul;230(3):177-84.

21.

Direct nucleophilic addition to N-alkoxyamides.

Yanagita Y, Nakamura H, Shirokane K, Kurosaki Y, Sato T, Chida N.

Chemistry. 2013 Jan 7;19(2):678-84. doi: 10.1002/chem.201202639. Epub 2012 Nov 14.

PMID:
23165728
22.

Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer.

Yamaki S, Fujii T, Yajima R, Hirakata T, Yamaguchi S, Fujisawa T, Tsutsumi S, Asao T, Yanagita Y, Iijima M, Kuwano H.

Surg Today. 2013 Aug;43(8):901-5. doi: 10.1007/s00595-012-0378-3. Epub 2012 Oct 23.

PMID:
23090139
23.

Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.

Iwata H, Masuda N, Sagara Y, Kinoshita T, Nakamura S, Yanagita Y, Nishimura R, Iwase H, Kamigaki S, Takei H, Tsuda H, Hayashi N, Noguchi S.

Cancer. 2013 Feb 15;119(4):704-13. doi: 10.1002/cncr.27818. Epub 2012 Sep 12.

24.

cGMP-dependent protein kinase I is involved in neurite outgrowth via a Rho effector, rhotekin, in Neuro2A neuroblastoma cells.

Yuasa K, Nagame T, Dohi M, Yanagita Y, Yamagami S, Nagahama M, Tsuji A.

Biochem Biophys Res Commun. 2012 May 4;421(2):239-44. doi: 10.1016/j.bbrc.2012.03.143. Epub 2012 Apr 4.

PMID:
22503686
25.

Astellas' drug discovery strategy: focus on oncology.

Yanagita Y, Takenaka T.

Jpn J Clin Oncol. 2012 Apr;42(4):241-6. doi: 10.1093/jjco/hys014. Review.

26.

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.

Masuda N, Sagara Y, Kinoshita T, Iwata H, Nakamura S, Yanagita Y, Nishimura R, Iwase H, Kamigaki S, Takei H, Noguchi S.

Lancet Oncol. 2012 Apr;13(4):345-52. doi: 10.1016/S1470-2045(11)70373-4. Epub 2012 Jan 20.

PMID:
22265697
27.

The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.

Fujisawa T, Hirakata T, Yanagita Y, Iijima M, Horikoshi H, Takeuchi K, Saitoh Y.

Breast Cancer. 2013 Jan;20(1):75-82. doi: 10.1007/s12282-011-0311-4. Epub 2011 Dec 28.

PMID:
22203579
28.

Incidence and risk factors of vascular complications following endovascular treatment of peripheral arterial disease via the popliteal artery.

Yanagita Y, Noda K.

Cardiovasc Interv Ther. 2011 Sep;26(3):209-14. doi: 10.1007/s12928-011-0060-5. Epub 2011 Apr 14.

PMID:
24122587
29.

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.

Aogi K, Sakai H, Yoshizawa H, Masuda N, Katakami N, Yanagita Y, Inoue K, Kuranami M, Mizutani M, Masuda N.

Support Care Cancer. 2012 Jul;20(7):1507-14. doi: 10.1007/s00520-011-1239-0. Epub 2011 Aug 2.

PMID:
21808994
30.

Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized study.

Anan K, Mitsuyama S, Yanagita Y, Kimura M, Doihara H, Komaki K, Kusama M, Ikeda T.

Breast Cancer Res Treat. 2011 Aug;128(3):775-81. doi: 10.1007/s10549-011-1608-x. Epub 2011 Jun 3.

PMID:
21638048
31.

Accuracy of intraoperative macroscopic diagnosis of sentinel node metastases in breast cancer: is accurate prediction possible?

Fujii T, Yanagita Y, Kinoshita T, Fujisawa T, Hirakata T, Yamaki S, Matsumoto A, Uchida N, Iijima M, Kuwano H.

Tumori. 2011 Jan-Feb;97(1):62-5.

PMID:
21528666
32.

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer.

Masuda N, Iwata H, Rai Y, Anan K, Takeuchi T, Kohno N, Takei H, Yanagita Y, Noguchi S.

Breast Cancer Res Treat. 2011 Apr;126(2):443-51. doi: 10.1007/s10549-010-1332-y. Epub 2011 Jan 8.

PMID:
21221770
33.

[Tolerability and safety of docetaxel plus cyclophosphamide as adjuvant chemotherapy for axillary lymph node-negative breast cancer--JECBC04 trial].

Yamamoto N, Tabei T, Inoue K, Takei H, Sato N, Yanagita Y, Fujisawa T, Fujii H, Saeki T, Kurosumi M.

Gan To Kagaku Ryoho. 2010 Jan;37(1):57-63. Japanese.

PMID:
20087033
34.

Implication of extracapsular invasion of sentinel lymph nodes in breast cancer: prediction of nonsentinel lymph node metastasis.

Fujii T, Yanagita Y, Fujisawa T, Hirakata T, Iijima M, Kuwano H.

World J Surg. 2010 Mar;34(3):544-8. doi: 10.1007/s00268-009-0389-4.

PMID:
20066412
35.

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial.

Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, Inoue K, Kitagawa C, Ogura T, Mitsuhashi S.

Lancet Oncol. 2009 Feb;10(2):115-24. doi: 10.1016/S1470-2045(08)70313-9. Epub 2009 Jan 8. Erratum in: Lancet Oncol. 2010 Mar;11(3)226.

PMID:
19135415
36.

Endoscopy-assisted subcutaneous mastectomy and immediate breast reconstruction for breast cancer: advantage of the posterior approach.

Yamaguchi S, Asao T, Uchida N, Yanagita Y, Saito K, Yamaki S, Kuwano H.

Int Surg. 2008 Mar-Apr;93(2):99-102.

PMID:
18998289
37.

Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.

Nishimura R, Tominaga T, Kimura M, Yanagita Y, Tamaki N, Asaishi K, Okamoto Y, Okuyama N, Takeuchi H, Inaba M, Doi T.

Anticancer Drugs. 2008 Oct;19(9):911-5. doi: 10.1097/CAD.0b013e3283099e71.

PMID:
18766005
38.

Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.

Kimura M, Sano M, Fujimori M, Nakagomi H, Negishi T, Yanagita Y, Sato N.

Anticancer Res. 2008 Mar-Apr;28(2B):1239-44.

39.

Relationship between the signal ratios of HER-2/CEP17 and c-MYC/CEP17 and the pathological response of neoadjuvant therapy using docetaxel and trastuzumab in breast cancer.

Kurosumi M, Tabei T, Sano M, Honma K, Yanagita Y, Yamamoto N, Inoue K, Sato N, Kimura M.

Mol Med Rep. 2008 Jan-Feb;1(1):71-5.

PMID:
21479380
40.

Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery.

Kimura M, Yanagita Y, Fujisawa T, Koida T.

Breast Cancer Res Treat. 2007 Dec;106(3):407-11. Epub 2007 Feb 1.

PMID:
17268809
41.

[Multicenter phase II trial of thrice-weekly docetaxel and weekly trastuzumab as preoperative chemotherapy in patients with HER 2-overexpressing breast cancer--Japan East Cancer Center Breast Cancer Consortium (JECBC) 02 Trial].

Sano M, Tabei T, Suemasu K, Yanagita Y, Yamamoto N, Asaga T, Ando J, Fujii H, Inoue K, Sato N, Takei H, Kurosumi M, Honma K, Kimura M.

Gan To Kagaku Ryoho. 2006 Oct;33(10):1411-5. Japanese.

PMID:
17033229
42.
43.

The use of nonionized contrast media with surgical biopsies for nonpalpable microcalcified breast lesions.

Yamaguchi S, Yanagita Y, Uchida N, Saitoh K, Yamaki S, Asao T, Kuwano H.

Breast J. 2006 May-Jun;12(3):285-6. Review. No abstract available.

PMID:
16684337
44.

Videoscopic thyroidectomy with fine needle-type apparatuses: an approach that does not leave a scar on the neck or anterior chest.

Asao T, Kuwano H, Yamaguchi S, Uchida N, Yanagita Y.

Surg Laparosc Endosc Percutan Tech. 2005 Dec;15(6):339-44.

PMID:
16340565
45.

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, Ogawa T, Ohwada S, Morishita Y, Ohta H, Im DS, Tamoto K, Tomura H, Okajima F.

J Biol Chem. 2004 Feb 20;279(8):6595-605. Epub 2003 Dec 3.

46.

A study on telomerase activity and prognosis in breast cancer.

Kimura M, Koida T, Yanagita Y.

Med Oncol. 2003;20(2):117-26.

PMID:
12835514
47.

Tuberculosis of axillary lymph nodes with primary breast cancer.

Fujii T, Kimura M, Yanagita Y, Koida T, Kuwano H.

Breast Cancer. 2003;10(2):175-8.

PMID:
12736574
48.

MR imaging of mucinous carcinoma of the breast.

Kawashima M, Tamaki Y, Nonaka T, Higuchi K, Kimura M, Koida T, Yanagita Y, Sugihara S.

AJR Am J Roentgenol. 2002 Jul;179(1):179-83.

PMID:
12076930
49.

Clinicopathological study of unilateral multiple breast cancer.

Koida T, Kimura M, Yanagita Y, Ogawa A, Sugihara S, Kuwano H.

Breast Cancer. 2001;8(3):202-5.

PMID:
11668241
50.

The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.

Kuwasako K, Kitamura K, Ito K, Uemura T, Yanagita Y, Kato J, Sakata T, Eto T.

J Biol Chem. 2001 Dec 28;276(52):49459-65. Epub 2001 Oct 8.

Supplemental Content

Loading ...
Support Center